Larimar Therapeutics, Inc. (LRMR)
3.32
-0.54
(-14.10%)
USD |
NASDAQ |
Sep 24, 16:00
3.32
0.00 (0.00%)
After-Hours: 19:59
Larimar Therapeutics Price to Book Value : 2.721 for Sept. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 24, 2026 | 2.721 |
| September 23, 2026 | 3.167 |
| September 22, 2026 | 3.130 |
| September 21, 2026 | 3.138 |
| September 18, 2026 | 3.106 |
| September 17, 2026 | 3.114 |
| September 16, 2026 | 3.220 |
| September 15, 2026 | 3.204 |
| September 14, 2026 | 3.098 |
| September 11, 2026 | 3.212 |
| September 10, 2026 | 3.155 |
| September 09, 2026 | 3.171 |
| September 08, 2026 | 3.339 |
| September 04, 2026 | 3.138 |
| September 03, 2026 | 3.138 |
| September 02, 2026 | 3.171 |
| September 01, 2026 | 3.229 |
| August 31, 2026 | 3.130 |
| August 28, 2026 | 3.286 |
| August 27, 2026 | 3.319 |
| August 26, 2026 | 3.417 |
| August 25, 2026 | 3.409 |
| August 24, 2026 | 3.319 |
| August 21, 2026 | 3.425 |
| August 20, 2026 | 3.409 |
| Date | Value |
|---|---|
| August 19, 2026 | 3.483 |
| August 18, 2026 | 3.327 |
| August 17, 2026 | 3.540 |
| August 14, 2026 | 3.573 |
| August 13, 2026 | 3.499 |
| August 12, 2026 | 3.581 |
| August 11, 2026 | 3.532 |
| August 10, 2026 | 3.286 |
| August 07, 2026 | 3.409 |
| August 06, 2026 | 3.442 |
| August 05, 2026 | 3.360 |
| August 04, 2026 | 3.368 |
| August 03, 2026 | 3.261 |
| July 31, 2026 | 3.130 |
| July 30, 2026 | 3.134 |
| July 29, 2026 | 2.975 |
| July 28, 2026 | 3.138 |
| July 27, 2026 | 3.138 |
| July 24, 2026 | 3.278 |
| July 23, 2026 | 3.286 |
| July 22, 2026 | 3.294 |
| July 21, 2026 | 3.220 |
| July 20, 2026 | 3.138 |
| July 17, 2026 | 3.032 |
| July 16, 2026 | 3.007 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.922 |
| Alnylam Pharmaceuticals, Inc. | 24.65 |
| Anika Therapeutics, Inc. | 1.972 |
| Savara, Inc. | 7.249 |
| Vericel Corp. | 5.435 |
Price to Book Value Related Metrics
| PEG Ratio | -0.062 |
| Price | 3.32 |
| Earnings Yield | -59.73% |
| Market Cap | 346.55M |
| PEGY Ratio | -0.062 |